Introduction
 Cardiovascular (CV) diseases are the most common causes of death and causes frequent hospital admissions. [1] The increase in life expectancy and the appearance of new treatments, [2] is changing in the clinical profile of CV disease, with a rise in chronic processes and concomitant comorbidities. [3] These changes are probably reflected in the current profile of patients admitted to cardiology departments, and in their causes of mortality.
The coronary care units emerged at the end of the 1960s, [4] with the aim of improving the care provided to patients with acute myocardial infarction. With the generalization of these units, there has been an important evolution and a great diversification of patients and diagnoses of admission. The causes of mortality in these units, as well as the treatment administered, invasive procedures or palliative interventions could differ from patients who are admitted to the conventional hospitalization ward. Most of the studies concerning the mode of death in cardiology departments are old, previous to reperfusion era [5] [6] [7] or do not address current important issues, such as end-of-life decisions regarding therapeutic support. [4, 8] Our main objective was to characterize the causes of death, the therapeutic support, and decisions on life-sustaining therapies at the end-of-life. We also aimed to determine the independent predictors associated with a higher likelihood of receiving comfort measures or a palliative intervention at the end-of-life.
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Methods

Data collection
We performed an observational retrospective study, including all deaths that took place in the cardiology department of an academic hospital during a 5-years period (from 1 st January, 2013 to 31 st December, 2017). Data were extracted from hospital administrative lists, and information related with the hospital admission and mode of death was collected from the medical electronic records or autopsy reports (when available).
Patients were classified according the place of death (intensive cardiac care unit or conventional ward). The variables reported include demographic data, patients' previous medical history, and diagnoses at admission. Mortality causes were classified as CV or non-CV, according to the previous definitions of the Standardized Data Collection for CV Trials Initiative (SCTI) and the U.S. Food and Drug Administration (FDA). [9] We made a distinction between primary (underlying disease that started the chain of events resulting in death) and intervening causes of death (other conditions that contribute to death). [9] Regarding in hospital treatment, the variables recorded included "do-not-resuscitate" orders, palliative measures/comfort medications (defined as interventions that provide immediate symptoms relief in patients close to death), and invasive life-sustaining therapies (renal replacement therapy, intra-aortic balloon pump, mechanical ventilation, or inotropes). We also differentiated between patients with a previous "do-not-resuscitate" order and unexpected deaths (those occurring in patients with on-going therapeutic efforts). Limitation of therapeutic effort was defined as the decision based on the http://www.jgc301.com; jgc@jgc301.com | Journal of Geriatric Cardiology status and prognosis of a patient to not apply treatments or perform procedures that would prolong agony. [10] 
Statistical analysis
Quantitative variables are presented as mean ± SD, or median (interquartile rank) for non-normally distributed variables. Categorical variables are presented as frequencies and percentages. Continuous quantitative variables were compared using Student's t-test and ANOVA for the comparison of means or the Wilcoxon rank sum in non-parametric data, and the categorical variables with the χ 2 test and the Fischer exact test. Bonferroni's correction was applied for multiple comparisons. A significance level of 0.05 (bilateral) was set for all statistical tests. Multivariate analysis included multiple logistic regression modelling techniques, for the primary endpoints. To determine which variables were entered into the final model, we used a sequential inclusion and exclusion method, with an inclusion p threshold lower than 0.05 and exclusion over than 0.1. All analyses were performed with the STATA software (Version 14.0).
This study accomplishes with the Declaration of Helsinki and was approved by the Ethics Committee of Clinical Investigation, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Results
During the study period a total of 500 deaths were recorded in our cardiology department. Mean age was 74.2 ± 13.1 years, and 186 (37.2%) were women. The more common diagnoses at admission were heart failure 181 (36.2%) and cardiac arrest 145 (29.0%). The clinical profile according to the diagnoses of admission is depicted in Table 1 . CV causes of death were found as the primary cause of mortality in 407 patients (81.4%). Non-CV causes were the leading cause of mortality in 93 patients (18.6%), and acted as an intervening cause of death in 182 (36.4%). Therefore, globally, a non-CV cause played a role in 275 patients (55.0%). Table 1 also describes the therapeutic efforts according to the diagnosis of admission. Patients with heart failure received more frequently a limitation of therapeutic effort, a less aggressive treatment, and more comfort measures compared to the rest of diagnoses of admission. Patients who were admitted for heart failure decompensation had an advanced age, presented frequent comorbidities and often had a non-cardiac cause of mortality [especially infections 41 patients (39.8%)]. Other less common causes of death included mechanical complications of acute coronary syndromes in 23 patients, pulmonary embolism in 10 patients, periprocedural complications in 6 patients, and bradycardia in 2 patients (in both cases a conservative approach was preferable due to advanced age and dementia).
Most of the fatalities occurred in the cardiac intensive care unit [354 patients (70.8%)], and those patients' clinical characteristics and mode of death were different from the ones that died in the cardiology ward ( Half of the patients admitted after presenting a resuscitated cardiac arrest died due to neurologic injuries (hypoxicischemic encephalopathy). Mortality after resuscitated cardiac arrest had a biphasic pattern, with an early peak in the first 24 hours due to hemodynamic instability, and a second peak over the 5 th day, due to hypoxic encephalopathy (Figure 1) . Table 3 shows the comparative analysis between patients with a previous "do-not-resuscitate" order and those with on-going therapy.
Treatments administered during the last 24 hours of life are depicted in Figure 2 . About a quarter of patients received inotropes, antibiotics, or antiplatelet agents. A total of 40 patients had an implantable cardioverter defibrillator, but information about therapies deactivation was only registered in the medical records of 14 patients (34.2%).
The independent predictors associated with limitation of therapeutic effort, and comfort measures administrations before death are depicted in Table 4 . After adjusting for clinical characteristics and comorbidities, the strongest predictors of withdrawing life-sustaining therapies were heart failure or hypoxic-ischemic encephalopathy. Death due to CV causes (except death due to pump failure) was associated with a lower probability of both a "do-not-resuscitate" order, and comfort measures administration before death.
Patients dying with heart failure presented the longest length of hospital stay (15.3 ± 29.7 days). After excluding heart failure deaths, duration of hospital admission tended to be shorter in patients who died due to a CV cause (5.6 ± 11.0 days), compared to those with a non-CV cause of death (20.4 ± 43.2 days), P = 0.04. 
Discussion
Our study shows that more than three quarters of the deaths occurring in a cardiology department occur in patients with a prior "do-not-resuscitate" order. "Pump failure" is the most common cause of death, but non-CV causes are also frequent. Limitation of therapeutic effort is more frequent in patients admitted with heart failure than in those admitted due to cardiac arrest or acute coronary syndrome. Heart failure patients also received more comfort measures before death than those hospitalized for other reasons. Patients who died in the cardiac intensive care unit received less comfort measures/palliative interventions before death than those admitted to the conventional ward.
As it was expected, patients with a "do-not-resuscitate" order were older, and presented more associated CV diseases and comorbidities. It is remarkable that dying due to a CV cause was associated with a lower rate of therapeutic withdrawal, compared to a non-CV cause. This observation has also been found in previous studies. [11, 12] A proposed explanation is that patients who die due to a CV condition are more likely to present hemodynamic instability leading to a rapid death, and consequently, a shorter length of hospital stay. [12] By contrast, non-CV deaths are often related to intractable multiorgan failure, [12, 13] and can be easily predicted.
We have found that nearly 90% deaths in the conventional ward were expected (occurred after withholding a treatment procedure due to perceived futility) and consequently, therapeutic efforts had been limited before death. A similar proportion has been found in a previous study performed in an internal medicine ward. [14] In our cardiac intensive care unit, about three quarters of patients who died had a prior "do-not-resuscitate" order. This proportion contrasts with the significantly lower percentage of patients who received a palliative approach and comfort measures (interventions aimed at providing an immediate relief of symptoms), which did not reach 60% of deaths at the cardiac intensive care unit. The limitation of therapeutic effort in the intensive care unit is still a pending issue, [15] and palliative care is frequently not incorporated into daily clinical practice despite its proven efficacy. [16, 17] It has been estimated that about one in five deaths documented in the United States may occur in a critical care bed, [15] but in our cardiology department such proportion was higher (nearly three quarters).
Decisions regarding withholding/withdrawing life-sustaining therapies take into account several factors and vary widely between geographical areas. [18] In this sense, prognostic information is crucial, [15] and this fact was consistent with the findings of our study, as the two strongest predictors regarding limitation of therapeutic effort were dying due to hypoxic encephalopathy and terminal heart failure. As we have noted in this registry, admissions after presenting a resuscitated cardiac arrest accounted for approximately one third of the deaths, and in this group hypoxic encephalopathy was the main reason of death. By contrast, although cognitive impairment has traditionally been an independent predictor of therapeutic effort limitation, [19] this was not the case in our study. Patients who died in our department were mainly male. This fact could be explained by the higher prevalence of CV disease in men, [20] and also a greater frailty in women; [21, 22] who would be probably referred to other wards, such as internal medicine or geriatrics.
Regarding patients who were admitted due to heart failure, death due to "pump failure" or terminal heart failure was the most common cause of death, as it has been previously described. [2, [23] [24] [25] These patients had common comorbidities and received lesser aggressive treatments at the end of life than patients who died of other causes or had different diagnoses at admission.
There seems to be field for improvement. For example, in carriers of implantable cardioverter defibrillators, a written record of deactivation was only found in a minority of cases, despite the previous decision to limit the therapeutic effort. This situation has also been described in a previous experience. [26] In this sense, it is important to involve in an early phase all the professionals who take care of these patients. [26] In addition, there was a very high prescription of medications that can be considered futile in patients with a limited life expectancy and a near death.
Limitations
This study has some limitations. The presented data correspond to the experience of a single center, and there could be differences with other cardiology departments. In addition, our study analyses only the deaths during admission and no information was collected from other patients. However, our study provides detailed information about the causes of mortality, end-of-life management, and suggests opportunities for future improvement, especially in patients with end-stage heart disease.
Conclusions
More than three quarters of the deaths occurring in a cardiology department occurs in patients with a previous "do-not-resuscitate" order, but not all patients receive comfort or palliative measures before death. We have found a http://www.jgc301.com; jgc@jgc301.com | Journal of Geriatric Cardiology high prescription of life-sustaining therapies the last 24 hours of life. Heart failure was the most frequent diagnosis and the limitation of therapeutic effort was more common in this group than in the rest of diagnoses. Patients who died in the cardiac intensive care unit received less palliative measures before death.
